
Sign up to save your podcasts
Or


Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
By John Simboli5
77 ratings
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.

3,063 Listeners

1,986 Listeners

1,094 Listeners

2,338 Listeners

945 Listeners

796 Listeners

126 Listeners

337 Listeners

6,135 Listeners

90 Listeners

10,205 Listeners

564 Listeners

151 Listeners

248 Listeners

188 Listeners